Washington DC-based biotech startup dedicated to innovating cell-based technologies for treatments at the point-of-care. We believe in the possibility of patients becoming "self-repairing" by using their OWN stem cells to replenish and restore cells in degenerative diseases that have undergone damage.
Cellular therapy is 10-15% of all clinical applications today and only rising with an aging population. Led by a team of scientists, our founders and members have previously succeeded in utilizing iterative iPSC technologies for rapid tissue-specific regeneration, and patient-specific primary cellular applications sanctioned by the FDA for investigational use in phase I clinical trials. Our team is innovating novel devices and applications using AI modeling to leverage personalized stem cell therapies for disease-specific needs. Currently approaching our next round, we are dedicated to enhancing stem cell treatment paradigms by changing the face of stem cell technologies at bed-side.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 2001 L St Nw, Washington,district Of Columbia 20036,united States
- Industry
- Biotechnology
- Website
- https://www.atpoint.io
- Keywords
- Stem cells, Regenerative medicine, Medical devices, Biotechnology, Cell engineering, Translational medicine, Clinical care, Cell therapy, Cancer.
- HQ
- Washington, District of Columbia
Atpoint Tx Questions
Atpoint Tx's website is https://www.atpoint.io
Atpoint Tx's LinkedIn profile is https://www.linkedin.com/company/atpoint-tx
Atpoint Tx has
1 employees.
View email and phone details for 1
employees at Atpoint Tx.
Atpoint Tx's industry is
Biotechnology
Atpoint Tx's top competitors are
Center For Complex Systems,
Sdd (Software Design & Development) Conference,
Precision Quantomics,
Allakos Inc,
Hstar Space,
Plastus Biotech,
Atpoint Llc,
Dabdoob,
Saudi Students Association At Sjsu,
New Resources Consulting.
Atpoint Tx's categories are Biotechnology
Atpoint Tx's founding year is 2022
